Back

Joint analysis of single-cell and bulk tissue sequencing data to reveals the adaptation and remodeling of the tumor microenvironment by breast cancer cells at different stages of brain metastasis process

Zhang, Y.; Huang, Z.; Wu, X.

2023-07-15 cancer biology
10.1101/2023.07.13.548875 bioRxiv
Show abstract

ObjectiveTo integrate macro-transcriptomics and single-cell sequencing to analyze the differential gene expression between primary and brain metastatic breast cancer cells, as well as between active and dormant cancer cells within brain metastases, exploring their adaptation and remodeling abilities at different stages of brain metastasis. MethodsFour public datasets were used: three mRNA microarray datasets from breast cancer and brain metastasis tissues, and one single-cell RNA sequencing (scRNA-seq) dataset from active and dormant brain metastatic cells. Gene differential expression, pathway enrichment, and cell clustering analyses were performed to compare primary and metastatic breast cancer cells, as well as active and dormant cells in brain metastases, focusing on gene expression, metabolic pathways, and functional pathways. ResultsMetastatic breast cancer cells showed weakened pathways related to the extracellular matrix and protein digestion. Active cells exhibited enhanced cell cycle regulation, tumor proliferation, and hypoxia resistance pathways compared to dormant cells. Clustering analysis revealed that cluster 6, unique to dormant cells, had enhanced functions in epithelial-mesenchymal transition (EMT), extracellular matrix (ECM), collagen formation, tumor inflammation siganure (TIS), and IL-10 signaling. Cluster 3 and 4 in active cells had enhanced DNA replication and tumor proliferation pathways, respectively. ConclusionThis study highlights the role of cancer cell characteristics and heterogeneity in the invasiveness of brain metastasis. Understanding these mechanisms can guide the development of more effective treatment strategies for breast cancer brain metastasis (BCBM) patients.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Translational Oncology
21 papers in training set
Top 0.1%
18.7%
2
Frontiers in Oncology
103 papers in training set
Top 0.1%
15.2%
3
Scientific Reports
3612 papers in training set
Top 8%
7.3%
4
PLOS ONE
5266 papers in training set
Top 24%
6.8%
5
eLife
5828 papers in training set
Top 34%
3.2%
50% of probability mass above
6
Biochemistry and Biophysics Reports
30 papers in training set
Top 0.2%
2.5%
7
Cancers
213 papers in training set
Top 2%
2.4%
8
BMC Cancer
67 papers in training set
Top 1.0%
2.1%
9
iScience
1154 papers in training set
Top 16%
1.7%
10
PeerJ
308 papers in training set
Top 6%
1.7%
11
International Journal of Molecular Sciences
494 papers in training set
Top 8%
1.7%
12
Cells
249 papers in training set
Top 4%
1.4%
13
Computational Biology and Chemistry
28 papers in training set
Top 0.5%
1.3%
14
Cell Death & Disease
126 papers in training set
Top 2%
1.1%
15
Communications Biology
993 papers in training set
Top 21%
1.1%
16
Genes to Cells
25 papers in training set
Top 0.3%
1.1%
17
Biomedicine & Pharmacotherapy
42 papers in training set
Top 1%
1.0%
18
Frontiers in Immunology
638 papers in training set
Top 8%
1.0%
19
Cancer Medicine
26 papers in training set
Top 0.9%
1.0%
20
Experimental Cell Research
28 papers in training set
Top 0.5%
1.0%
21
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.9%
22
Biomedicines
67 papers in training set
Top 3%
0.9%
23
Molecular Cancer Research
49 papers in training set
Top 1%
0.9%
24
Theranostics
37 papers in training set
Top 1%
0.9%
25
Journal of Translational Medicine
57 papers in training set
Top 2%
0.9%
26
Cancer Research
130 papers in training set
Top 3%
0.8%
27
Neoplasia
23 papers in training set
Top 1.0%
0.6%
28
Heliyon
152 papers in training set
Top 9%
0.6%
29
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 6%
0.6%
30
Frontiers in Genetics
230 papers in training set
Top 6%
0.6%